New-onset versus prior history of atrial fibrillation: Outcomes from the AFFIRM trial

American Heart Journal

Volumn 170, Issue 1, 2015, Pages 156-163.e1

  Damluji, Abdulla A ^a   Al Damluji, Mohammed S ^b   Marzouka, George R ^a   Coffey, James O ^a   Viles Gonzalez, Juan F ^a   Cohen, Mauricio G ^a   Moscucci, Mauro ^a   Myerburg, Robert J ^a   Mitrani, Raul D ^a  

^a UNIVERSITY OF MIAMI HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

ADVERSE OUTCOME; AGED; ARTICLE; ATRIAL FIBRILLATION; BLEEDING; BRAIN DISEASE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROL STRATEGY; CONTROLLED STUDY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HEART ARREST; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; NEW-ONSET ATRIAL FIBRILLATION; OUTCOME ASSESSMENT; PREDICTION; PRIOR HISTORY OF ATRIAL FIBRILLATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; COMPARATIVE STUDY; LONGITUDINAL STUDY; MIDDLE AGED; MORTALITY; PATIENT CARE PLANNING; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STROKE;

AGED; ANTI-ARRHYTHMIA AGENTS; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HEART FAILURE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT CARE PLANNING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STROKE;

EID: 84931575852     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.04.020     Document Type: Article

References (14)

1. S. Baldasseroni, F. Orso, and G. Fabbri Age-dependent prognostic significance of atrial fibrillation in outpatients with chronic heart failure: data from the Italian Network on Congestive Heart Failure Registry Cardiology 116 2010 79 88
2. J.P. Piccini, B.G. Hammill, and M.F. Sinner Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007 Circ Cardiovasc Qual Outcomes 5 2012 85 93
3. D.D. McManus, J.S. Saczynski, and D. Lessard Recent trends in the incidence, treatment, and prognosis of patients with heart failure and atrial fibrillation (the Worcester Heart Failure Study) Am J Cardiol 111 2013 1460 1465
4. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
5. A.L. Waldo, R.C. Becker, and V.F. Tapson Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation J Am Coll Cardiol 46 2005 1729 1736
6. Atrial fibrillation follow-up investigation of rhythm management - the AFFIRM study design. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators Am J Cardiol 79 1997 1198 1202
7. L. Kober, K. Swedberg, and J.J. McMurray Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction Eur J Heart Fail 8 2006 591 598
8. C.N. Bang, G.H. Gislason, and A.M. Greve New-onset atrial fibrillation is associated with cardiovascular events leading to death in a first time myocardial infarction population of 89,703 patients with long-term follow-up: a nationwide study J Am Heart Assoc 3 2014 e000382
9. E.J. Benjamin, P.A. Wolf, and R.B. D'Agostino Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
10. S.D. Corley, A.E. Epstein, and J.P. DiMarco Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study Circulation 109 2004 1509 1513
11. O.D. Pedersen, H. Bagger, and N. Keller Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy Circulation 104 2001 292 296
12. M.H. Raitt, A.S. Volgman, and R.G. Zoble Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Am Heart J 151 2006 390 396
13. F.G. Cosio, E. Aliot, and G.L. Botto Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode Europace 10 2008 21 27
14. C.T. January, L.S. Wann, and J.S. Alpert 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society Circulation 130 2014 2071 2104